Detection of macrolide resistant Mycoplasma pneumoniae in England, September 2014 to September 2015

Rebecca J Brown1, Louissa Macfarlane-Smith, Sarah Phillips

  • 1Bacteriology Reference Department, Public Health England (PHE), London, United Kingdom.

Insights

Macrolide resistance is emerging in Mycoplasma pneumoniae, a common cause of childhood pneumonia. This study found resistance mutations in nearly 10% of cases in England and Wales, necessitating increased clinical awareness.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Mycoplasma pneumoniae is a significant cause of community-acquired pneumonia, especially in pediatric populations.
  • The rise in macrolide-resistant M. pneumoniae strains globally poses a therapeutic challenge due to limited alternative treatments.

Purpose of the Study:

  • To investigate the prevalence of macrolide resistance-conferring mutations in M. pneumoniae within clinical specimens from England and Wales.
  • To inform healthcare professionals about the presence of macrolide resistance in M. pneumoniae infections.

Main Methods:

  • Analysis of 43 clinical specimens positive for M. pneumoniae.
  • Detection of specific mutations associated with macrolide resistance.

Main Results:

  • Macrolide resistance-conferring mutations were identified in 9.3% of the analyzed M. pneumoniae clinical specimens.
  • The study period was from September 2014 to September 2015.

Conclusions:

  • The findings highlight the circulation of macrolide-resistant M. pneumoniae in England and Wales.
  • Increased clinical vigilance is recommended for patients with M. pneumoniae infections to ensure appropriate treatment strategies.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
37
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
95
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
29
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K